Loki Therapeutics

[Available On-Demand]
Loki focuses on treating solid tumors and metastases through the activation and redirection of memory T-cells. Our patent AWAKE platform allows the targeting and elimination of a wide variety of difficult to treat cancers, including advanced pancreatic and ovarian cancers.
Company Type:
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
AWAKE-LM-TT
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Loki Therapeutics